<DOC>
	<DOCNO>NCT00828763</DOCNO>
	<brief_summary>Mass balance study determine recovery single radiolabelled dose GSK1349572 urine feces</brief_summary>
	<brief_title>GSK1349572 Mass Balance Study</brief_title>
	<detailed_description />
	<mesh_term>Dolutegravir</mesh_term>
	<criteria>Healthy determine responsible physician , base medical evaluation include medical history , physical examination , laboratory test cardiac monitoring . Male subject 30 55 year age . Male subject must agree use one contraception method list protocol . This criterion must follow time first dose study medication 84 day dose study medication . Body weight ≥ 50 kg body mass index ( BMI ) within range 18.531.0 kg/m2 ( inclusive ) . Capable give write informed consent , include compliance requirement restriction list consent form . Available complete study ( minimum 6 maximum 11 night confinement clinical research unit ) . A history regular bowel movement ( average one bowel movement per day ) . AST , ALT , alkaline phosphatase bilirubin ≤ 1.5xULN ( isolated bilirubin &gt; 1.5xULN acceptable bilirubin fractionate direct bilirubin &lt; 35 % ) . A single repeat allow eligibility determination . The subject positive prestudy drug/alcohol screen . A minimum list drug screen include amphetamine , barbiturate , cocaine , opiates , cannabinoids benzodiazepine . The subject participate clinical trial receive investigational product within following time period prior first dose day current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . History sensitivity study medication , component thereof , history drug allergy , opinion investigator GSK Medical Monitor , contraindicate participation . Use prescription nonprescription drug , include antacid , vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion Investigator GSK Medical Monitor medication interfere study procedure compromise subject safety . If heparin use PK sample , subject history sensitivity heparin heparininduced thrombocytopenia enrol . History regular alcohol consumption within 6 month study define average weekly intake &gt; 14 drinks/week . One drink equivalent ( 12 g alcohol ) = 5 ounce ( 150 ml ) wine 12 ounce ( 360 ml ) beer 1.5 ounce ( 45 ml ) 80 proof distil spirit . Has history regular use tobacco nicotinecontaining product within 3 month prior screen . Consumption red wine , seville orange , grapefruit grapefruit juice 7 day prior first dose study medication . Subjects received total body radiation dose great 5.0 mSv ( upper limit WHO category II ) exposure significant radiation ( e.g . serial xray CT scan , barium meal etc ) 12 month prior study . Any condition could interfere accurate assessment recovery radiocarbon [ 14C ] . Unwillingness inability follow procedure outline protocol . Subjects preexist condition interfere normal gastrointestinal anatomy motility , hepatic and/or renal function , could interfere absorption , metabolism , and/or excretion study drug . Subjects history cholecystectomy exclude . A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month screen . A positive test HIV antibody . Where participation study would result donation blood blood product excess 500 mL within 56 day period . The subject 's systolic blood pressure outside range 90140mmHg , diastolic blood pressure outside range 4590mmHg heart rate outside range 45100 bpm . A single repeat allow determine eligibility ECG within protocol criterion</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>healthy volunteer</keyword>
	<keyword>radiolabelled</keyword>
</DOC>